2.23 USD
↘ 0.10 (4.09%)LIVE (AS OF 11:28 AM EST)
Nautilus Biotechnolgy, Inc. Common Stock (NAUT) trades at $2.23 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. NAUT is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Nov 13, 2026.